• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Expert views
  • Green Chemistry Articles of Interest to the Pharmaceutical Industry

Green Chemistry Articles of Interest to the Pharmaceutical Industry

22 September 2022
Expert views

The American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACSGCI PR) promotes the use of green and sustainable chemistry in the pharma industry and beyond. As a part of this initiative, reviews covering Green Chemistry articles of interest from a pharmaceutical perspective are periodically disclosed.[…]

The American Chemical Society (ACS) Green Chemistry Institute (GCI) Pharmaceutical Roundtable (PR) was developed in 2005 to encourage the integration of green chemistry and green engineering into the pharmaceutical industry. The ACS GCI is a not-for-profit organization whose mission is to catalyze and enable the implementation of green and sustainable chemistry throughout the global chemistry enterprise. The ACS GCI PR is composed of pharmaceutical and biotechnology companies, including contract research/ manufacturing organizations and generic pharmaceuticals. For details of the current membership, see acsgcipr.org. Reviews covering Green Chemistry articles of interest from a pharmaceutical perspective are periodically disclosed.

Bryan, M. C.; Dalton, C.; Doerfler, J.; Engl, O. D.; Ferguson, P.; Molina, A. G.; Harawa, V.; Hosford, J.; Howell, G. P. Kelly, C. B.; Li, W.; Munday, R. H.; Navarro, A.; Parmentier, M.; Pawlas, J.; Richardson, P. F.; Steven, A.; Takale, B. S.; Terrett, J. A.; Treitler, D. S.; Zeng, M. Green Chemistry Articles of Interest to the Pharmaceutical Industry. Org. Process Res. Dev. 2022, 26, 2550–2559.

Read more

 

Back to news

Related posts

2 April 2025

Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis


Read more
20 March 2025

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase


Read more
13 November 2024

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers